Evidence map›Paper›PMID 30018139›Full record

ArticleThe Journal of biological chemistry2018

Deficiency in Fpr2 results in reduced numbers of Lin

Keqiang Chen, Peng Tang, Zhiyao Bao, Tianzhen He, Yi Xiang, Wanghua Gong, Teizo Yoshimura, Yingying Le, Lino Tessarollo, Xin Chen and 1 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 4 countries.

Keqiang ChenFrom the Cancer and Inflammation Program and.
Peng TangFrom the Cancer and Inflammation Program and.
Zhiyao BaoFrom the Cancer and Inflammation Program and.
Tianzhen Hethe State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR 999078, China.
Yi Xiangthe Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Wanghua Gongthe Basic Research Program, Leidos Biomedical Research, Inc., Frederick, Maryland 21702.
Teizo Yoshimurathe Department of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan, and.
Yingying Lethe Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Lino TessarolloMouse Cancer Genetics Program, Center for Cancer Research, NCI, National Institutes of Health, Frederick, Maryland 21702.
Xin Chenthe State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR 999078, China.
Ji Ming WangFrom the Cancer and Inflammation Program and wangji@mail.nih.gov.
National Institutes of Health · USRuijin Hospital · CNUniversity of Macau · MOArmy Medical University · CNCenter for Cancer Research · USChinese Academy of Sciences · CNLeidos (United States) · USOkayama University · JPUniformed Services University of the Health Sciences · US

Funding

Gene Targeting FacilityZICBC011265 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TESSAROLLO, LINO · 2010 to 2025
$8.9M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

The Lin

Indexed as

Gene DeletionAnimalsAntigens, LyCell CountCell LineageCell ProliferationFemaleMaleMembrane ProteinsMiceMyeloid Progenitor CellsProto-Oncogene Proteins c-kitReceptors, Formyl PeptideAntigens, Lyformyl peptide receptor 2, mouseLy6a protein, mouseMembrane ProteinsProto-Oncogene Proteins c-kitReceptors, Formyl Peptidebone marrowc-KITcytokineFpr2Lin−c-Kit+Sca1+cellsmousemyeloid cellproliferationSCF

Identifiers

PMID30018139
PMCPMC6120191
OpenAlexW2883258569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.